ArticleScientific reports2026
Clinical and socioeconomic determinants of health-related quality of life among cancer patients in Southwestern Iran: a cross-sectional study.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer significantly affects multiple dimensions of patients' well-being, making health-related quality of life (HRQoL) a key outcome in oncology. However, evidence on the clinical and socioeconomic determinants of HRQoL among cancer patients in Iran, particularly in southwestern regions, remains limited. This study aimed to assess HRQoL and to identify its clinical and socioeconomic determinants among cancer patients in southwestern Iran. This cross-sectional descriptive-analytical study was conducted in 2024 among cancer patients attending Shahid Jalil Hospital, Yasuj. A total of 166 eligible patients were recruited through consecutive sampling. HRQoL was assessed using the validated Persian version of the EORTC QLQ-C30. Sociodemographic, clinical, and treatment-related variables were collected through structured interviews and medical records. Data analysis was performed using SPSS 27. Median (IQR) values were reported for HRQoL domains. The Gamma regression model with log link was applied to identify predictors of overall HRQoL. Associations were expressed as Mean Ratios (MRs) with 95% confidence intervals. Participants had a mean age of 58.09 ± 16.08 years; 54.2% were male, and 58.5% had stage IV cancer. The lowest HRQoL scores were observed in cognitive functioning (median: 32.33), physical functioning (38), and role functioning (49), while social functioning showed higher scores (65.67). In multivariable analysis, stage IV cancer (MR = 0.33; 95% CI: 0.14-0.80) and metastatic disease (MR = 0.36; 95% CI: 0.17-0.77) were strongly associated with reduced HRQoL. Conversely, basic health insurance significantly improved HRQoL (MR = 2.15; 95% CI: 1.06-4.36). Other demographic variables were not significant predictors. Disease severity and insurance coverage are major determinants of HRQoL among cancer patients in southwestern Iran. Enhancing early detection, strengthening financial protection, and integrating supportive and palliative care services may improve patient outcomes. Longitudinal studies are recommended to better elucidate HRQoL trajectories.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.